COMP <GO>
CGNX vs DRS // EV/EBITDA & P/E VALUATION
Cognex Corporation (NASDAQ) VS. Leonardo DRS Inc. (NASDAQ) • 15-METRIC TALLY: CGNX 7
— DRS 7
▲ EV/EBITDA & P/E VALUATION LEADER: DRS
LAST: $56.15 (-4.78%) • MKT CAP: $9.92B
valuation
58.1x
LAST: $37.68 (-4.94%) • MKT CAP: $10.58B
valuation
23.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGNX VS. DRS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CGNX | DRS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.90% | 23.80% | +43.10 | CGNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.90% | 9.20% | -0.30 | DRS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 58.1x | 23.2x | +34.90 | DRS | /valuation <GO> |
| Free Cash Flow Yield | 2.39% | 2.15% | +0.24 | CGNX | /fcf-yield <GO> |
| Operating Margin | 16.30% | 9.50% | +6.80 | CGNX | /operating-margins <GO> |
| Net Profit Margin | 11.50% | 7.60% | +3.90 | CGNX | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 12.80% | -4.10 | DRS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.55% | 0.00% | +0.55 | CGNX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.69 | 3.59 | +9.10 | CGNX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | CGNX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.9 | 63.6 | -12.70 | DRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.89 | -0.01 | DRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 80.6x | 32.0x | +48.60 | DRS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.92B | $10.58B | -$659.4M | DRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CGNX REV | DRS REV | CGNX GROSS % | DRS GROSS % | CGNX FCF | DRS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $994.4M | $3.65B | 66.9% | 23.8% | $236.8M | $227.0M |
| FY 2024 | $914.5M | $3.23B | 68.4% | 22.8% | $134.0M | $186.0M |
| FY 2023 | $837.5M | $2.83B | — | — | $75.2M | $77.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGNX // BETA 0.88
DRS // BETA 0.89